In the study published in The BMJ, scientists proposed that laughter exercises could be a promising home-based solution for ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...

Walnut oil is a nutrient powerhouse that can revolutionise your skin health with its high content of omega-3 fatty acids, ...

OKYO Pharma has filed a Fast Track designation application with the Food and Drug Administration (FDA) for urcosimod in the treatment of neuropathic ...

Kelly Vision Dr. Ashley Brissette Dr. James Kelly and Dr. Ashley Brissette NEW YORK , NY, UNITED STATES, March 10, 2025 /EINP ...

Nanomerics Ltd. announced the successful completion of its OC134 Phase I trial - the SUNLIGHT trial. With the clinical phase competed the trial for OC134 and the MET platform has met its primary ...

Preserve the longevity and safety of your contact lenses by avoiding these common mistakes, according to an optometrist.

RPESC-RPE-4W is a proprietary retinal pigment epithelium cell therapy for patients with dry age-related macular degeneration.

The Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel).

SightMD is pleased to announce that Gladys Lee, MD, a highly experienced and board-certified ophthalmologist, has joined ...